4.9 (641) In stock
Urovant Sciences, a wholly-owned subsidiary of Sumitovant Biopharma Ltd., announced the launch of Time To GoTM today, a multi-channel educational camp
Envestnet Insurance Exchange Powered By Collaboration Between FIDx & SIMON
Digital health news, funding round up in the prior week; November 21, 2022
Partner Therapeutics (PTx) Acquires Leukine® from Sanofi
METRO & the Interagency Mentor Protégé Program Partners Continue Their Collaboration to Advance, Strengthen & Drive the Small Business Community - Subcontractors USA
Salt's Environmental and Infrastructure Impacts - Bolton & Menk
Urovant Sciences® Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season
Nulogy CEO Jason Tham and VP Christine Barnhart Named 2023 Pros to Know by Supply & Demand Chain Executive
2024 Innovation Nexus Conference Program Speakers - American Urological Association
About Us Stimulus Technologies
Urovant Sciences® Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season
Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting
University of Toronto Entrepreneurship U of T Entrepreneurship Week 2024: 10 startups to watch - University of Toronto Entrepreneurship
시장보고서]세계의 과민성 방광 치료 시장(2022-2029년)
